ACCENDRA HEALTH INC (ACH) Forecast, Price Target & Analyst Ratings
NYSE:ACH • US6907321029
2.36 USD
-0.02 (-0.84%)
At close: Mar 6, 2026
2.36 USD
0 (0%)
After Hours: 3/6/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACCENDRA HEALTH INC (ACH).
Forecast Snapshot
Consensus Price Target
$3.32
+ 40.47% Upside
Next Earnings Forecast
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.10
Revenue Estimate652.82M
ChartMill Buy Consensus
50.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.32
Upside
+ 40.47%
From current price of $2.36 to mean target of $3.32, Based on 12 analyst forecasts
Low
$2.27
Median
$3.06
High
$5.25
Price Target Revisions
1 Month
-12.16%
3 Months
N/A
Price Target Summary
12 analysts have analysed ACH and the average price target is 3.32 USD. This implies a price increase of 40.47% is expected in the next year compared to the current price of 2.36.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.00%
ACH was analyzed by 12 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about ACH.
In the previous month the buy percentage consensus was at a similar level.
ACH was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2026-01-09 | Citigroup | Maintains | Buy -> Buy |
| 2022-08-25 | Goldman Sachs | Upgrade | Sell -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.10
Revenue Estimate652.82M
Revenue Q2Q-75.20%
EPS Q2Q-144.72%
Number of Analysts7
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
ACH is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 652.82M USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.553B -74.36% | 2.68B 5.00% | 2.762B 3.06% | 2.618B -5.21% | 2.734B 4.43% | 2.892B 5.78% | 3.251B 12.41% | N/A | |
| EBITDA YoY % growth | 502.741M 17.85% | 400.985M -20.24% | 340.453M -15.10% | 342.25M 0.53% | 373.4M 9.10% | 396.66M 6.23% | N/A | N/A | |
| EBIT YoY % growth | 215.364M 8.81% | 136.21M -36.75% | 125.929M -7.55% | 195.5M 55.25% | 231.16M 18.24% | 248.19M 7.37% | N/A | N/A | |
| Operating Margin | 8.44% | 5.08% | 4.56% | 7.47% | 8.46% | 8.58% | N/A | N/A | |
| EPS YoY % growth | 1.36 -43.57% | 1.52 11.76% | 0.95 -37.50% | 0.55 -41.95% | 0.97 75.82% | 1.22 25.71% | 1.25 2.75% | 1.62 29.03% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 -144.72% | 0.02 -93.46% | 0.26 4.54% | 0.31 49.10% | 0.20 296.41% | 0.23 1,266.61% | 0.29 12.08% | 0.31 |
| Revenue Q2Q % growth | 652.82M -75.20% | 636.69M -6.63% | 659.73M -5.39% | 678.89M -4.24% | 682.31M 4.52% | 690.45M 8.44% | 730.4M 10.71% | 749.58M 10.41% |
| EBITDA Q2Q % growth | 61.784M -43.20% | 75.092M -55.77% | 91.87M -56.62% | 99.47M -53.75% | 88.708M 43.58% | 91.718M 22.14% | 99.869M 8.71% | 102.45M 3.00% |
| EBIT Q2Q % growth | 25.219M -47.04% | 38.075M -22.66% | 58.161M 114.38% | 65.054M 11,685.14% | 53.49M 112.10% | 56.499M 48.39% | 64.65M 11.16% | 67.236M 3.35% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
10.53%
EPS Next 5 Year
11.07%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.18%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
6.40%
EBIT Next 5 Year
6.41%
ACCENDRA HEALTH INC / ACH Forecast FAQ
What is the price target for ACH stock?
12 analysts have analysed ACH and the average price target is 3.32 USD. This implies a price increase of 40.47% is expected in the next year compared to the current price of 2.36.
Can you provide the upcoming earnings date for ACCENDRA HEALTH INC?
ACCENDRA HEALTH INC (ACH) will report earnings on 2026-05-06, before the market open.
What are the consensus estimates for ACH stock next earnings?
The consensus EPS estimate for the next earnings of ACCENDRA HEALTH INC (ACH) is -0.1 USD and the consensus revenue estimate is 652.82M USD.
How do analysts rate ACCENDRA HEALTH INC (ACH)?
The consensus rating for ACCENDRA HEALTH INC (ACH) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.